Company Overview

AVI BioPharma Highlights:

Proven NeuGene antisense technology

  • Multiple preclinical and clinical trials
  • Excellent safety profile

Important clinical applications

  • Cardiovascular disease
  • Infectious diseases

New exon skipping technology

  • ESPRIT for diabetes, MS, MD

Late-stage drug development

  • Phase II and phase III programs

Strong patent position

  • Over 170 issued patents
  • Over 150 patents pending

Large market potential

  • Billion dollar markets

Resources

  • 120 employees
  • GMP manufacturing

Alliances